Newsroom, your daily review

Keep up with the latest in the tableting community!

Showing posts tagged as : #development

Feature article


March 23, 2021

A QbD approach to shorten tablets development time

Reducing “time to market” is the ultimate goal for every pharmaceutical lab. Being the first on the market brings a competitive advantage for prescription, over-the-counter, or generic-drug manufacturers. Applying quality-by-design (QbD) principles at the formulation phase can prevent tablet defects at an early stage and thereby drastically reduce time during the complex and troublesome phase of “scale-up”.

#troubleshooting #QbD #development

Press review

March 3, 2021

UCB and Microsoft announce digital drug R&D tie-up

UCB's announced a new partnership in order to integrate IA technologies as a tool for its development.The aim is to "significantly accelerate the iteration cycles required to identify more effective molecules".

The complete Press article can be found here.

#formulation #IA #UCB #development

Page 1 of 1

Publish with us!